Epithalon where to buy is a paperwork question wearing the costume of a shopping question. Every storefront uses the same photography, the same reassuring copy and the same greater-than-98-percent claim, so the only thing that varies is what each will show you about the specific vial it intends to put in a box with your name on it.
Key takeaways
- Epithalon is a synthetic tetrapeptide, four residues, Ala-Glu-Asp-Gly. It is sold on ageing claims. Nothing about it is marketed as a strength, hypertrophy or recovery outcome, and you should buy it knowing that.
- There is no compounding pharmacy route. Epitalon was nominated as a bulk substance, was placed in category 2 under FDA's interim policies, and the nomination was then withdrawn, so it sits on no current category list.
- FDA's stated concern is immunogenicity from aggregation and peptide-related impurities. That is a manufacturing and handling question, which is exactly what the criteria below are designed to test.
- The certificate on the vial we point to assays 9.64 mg against a 10 mg label, inside the stated tolerance but under the printed weight, which moves the honest unit price from $2.50/mg to $2.59/mg.
- Every criterion here is about documentation. Passing all eight tells you the material is what the label says. It tells you nothing about whether it does anything.
The listing scored later in this article is the one below, so the price and the batch are visible while you read the criteria rather than produced at the end as a conclusion.
The vendor we point lifters to
Epithalon from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The certificate for batch 15-05260628 assays this vial at 9.64 mg against a 10 mg label, inside the stated 10 percent tolerance, which puts the real figure at $2.59/mg on that batch. It carries purity, identity, endotoxin, sterility and heavy metals. Buying 3, 5 or 10 takes 3%, 5% or 10% off list.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 23, 2026.
Epithalon where to buy: the eight criteria, written before any storefront opens
Set the standard first. Open tabs first and the standard quietly becomes a description of whichever seller you already liked.
| Criterion | What a pass looks like | What a fail looks like |
|---|---|---|
| Batch-specific certificate | A report naming the lot printed on the vial you receive | A brand-level PDF with no lot on it |
| Purity against a specification | A percentage stated against a written acceptance limit | "99% pure" with no limit, no method and no document |
| Identity confirmation | The certificate confirms the molecule, checkable against a public formula and mass | No identity section at all, only a purity number |
| Endotoxin result | A figure or a pass against a stated acceptance limit | Silence, or the word "clean" |
| Sterility screen | A screen with a reported outcome on the certificate | "Sterile" printed on the marketing page and nowhere else |
| Measured net content | An assayed milligram figure per vial, not the label weight repeated | The number from the label quoted back to you as a result |
| Domestic stock and dispatch | A US warehouse, a stated cut-off, tracking within a day | "Ships worldwide", three week transit, no address |
| Research-use labelling | A seller that states the legal limits and offers no protocol | A seller volunteering dosing or cycles |
Six of those eight are settled by a single PDF. You are not choosing between companies, you are choosing between documents, and the document opens before you spend anything.
Four residues, and why the identity row is the cheapest one to check
Epithalon is a synthetic tetrapeptide. Four amino acids, Ala-Glu-Asp-Gly, usually written AEDG. It came out of work by Vladimir Khavinson's group in Russia, as a synthetic version of a pineal gland extract called epithalamin.
That makes the identity row easy to audit. PubChem lists the compound under CID 219042, giving the formula as C14H22N4O9 and the molecular weight as 390.35, under the spelling Epitalon that FDA also uses. The market, and this page, write Epithalon. Two spellings of one molecule, and a seller treating them as different products has told you something.
The criterion with no supplier attached
Readers keep looking for a legitimate prescription route, so here is the position precisely, because most competing pages get it wrong in one direction or the other.
Epitalon was nominated as a bulk drug substance for use in compounding. It was placed in category 2 under FDA's interim policies while the agency worked through it, and the nomination was subsequently withdrawn by the nominator. It now appears on FDA's bulk substances safety risks page, content current as of 04/22/2026, under the heading "Bulk drug substances nominated but withdrawn", a table FDA describes as covering substances previously in category 2 that the nominators pulled. It does not appear anywhere on the 503A bulk substances page, content current as of 05/14/2026, in category 1, 2 or 3.
So "Epitalon was in category 2" is stale, "Epitalon is category 2" is wrong, and "Epitalon is on no current category list" is the accurate sentence. There is no FDA approval for it for any indication either. The same withdrawn-nomination story applies to the two other Russian peptides on this site, and we set it out at length in Selank without a prescription.
There is therefore no pharmacy row to score, and a seller claiming a prescription pathway is not offering a better channel, it is telling you it does not know what it is selling.
Why endotoxin and sterility carry weight on this particular compound
FDA's own language about this substance is narrow, and it is worth reading as written rather than paraphrased into vagueness. Compounded drugs containing epitalon, the agency writes, "may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities", adding that it "has not identified safety-related information regarding epitalon for the proposed route of administration".
Notice what that is and is not. It is not a finding of harm. It is a statement that the agency cannot rule harm out, and that the risks it can name are manufacturing risks. Aggregation and peptide-related impurities come from how material was synthesised, purified, dried, filled, shipped and stored, and bacterial endotoxin belongs to the same family of problems.
That is why criteria four and five outrank criterion two on anything intended to be injected. A vial can be 99 percent pure and still carry an endotoxin load, because purity asks what fraction of the powder is the target molecule and endotoxin asks what came along with it. A limit of 0.5 EU/mL is the kind of acceptance limit the bacterial endotoxins test described in USP Chapter 85 is written around, and a certificate reporting against it has answered a question the marketing page cannot.
Scoring the listing above, line by line, including where it drops a mark
Here is the vial in the card measured against all eight rows. The certificate is for batch 15-05260628, analysed by Kovera Labs, report KVR-2026-A36FF4, certified 05/23/2026.
| Criterion | Result on this batch | Verdict |
|---|---|---|
| Batch-specific certificate | Lot 15-05260628, report KVR-2026-A36FF4, certified 05/23/2026 | Pass |
| Purity against a specification | 99.312% against a greater-than-98% specification | Pass |
| Identity confirmation | Identity confirmed on the certificate | Pass |
| Endotoxin result | Screened against a 0.5 EU/mL limit, reported as a pass | Pass |
| Sterility screen | Microbial screen returned no growth | Pass |
| Measured net content | 9.64 mg against a 10 mg label, specification 10 mg plus or minus 10 percent | Inside tolerance, under the label |
| Domestic stock and dispatch | US dispatch, same-day cut-off stated on the listing | Pass |
| Research-use labelling | Sold as research material, not for human consumption | Pass |
The sixth row is the reason this article exists in the form it does.
A vial labelled 10 mg assayed at 9.64 mg. That is inside the stated tolerance of plus or minus 10 percent, so nothing failed against the specification, and it is still under the printed weight. At $25.00 with the code, ten milligrams would be $2.50 per milligram. Against the 9.64 mg actually measured, the same $25.00 is $2.59 per milligram. Both numbers are true. Only one is on the marketing page, and this site prints the other one next to it every time.
Two things follow and they point in opposite directions. You get slightly less material than the label implies. You also get a vendor that published a measurement working against its own label copy, when the cheap option was to print the label weight in the results column and call it a day. On the neighbouring Russian peptide the same lab reported a lot running over its label rather than under, which we cover in where to buy Selank. Numbers landing on both sides of the line are a sign of reporting rather than performing.
One caveat on scope. For this compound a single certificate is published, covering batch 15-05260628, where the neighbouring Russian peptides carry two documents apiece. Testing scope belongs to a batch, not to a brand, so the question to ask any seller is not "do you test" but "what does the report for the lot you are shipping cover".
What a clean scorecard still does not buy
This is blunt because most readers of this site are lifters in their forties, fifties or beyond who found Epithalon while reading about ageing rather than about training.
Passing eight documentation criteria establishes that the powder is the molecule named on the vial, at a stated purity, screened for endotoxin and microbial growth, at a measured weight. It establishes nothing about effect. The marketing case for Epithalon rests on telomere and telomerase claims and on longevity results in animals and in a long-running cohort, and that body of work comes largely from one research group, largely in Russian-language publications, and has not been replicated to the standards a Western regulator or a cautious reader would want. A PubMed search for epitalon returns a modest literature dominated by that lineage of work, and a search of ClinicalTrials.gov returns no registered study listing it as an intervention at all. That last figure is the one to hold onto.
Be clear about the purchase. You are buying an anti-ageing claim, not a performance one. No seller is telling you it adds a kilo of muscle or shortens recovery between heavy sessions, and if one starts to, that is a reason to close the tab. If the real problem is that training capacity is not what it was at thirty, the mechanisms with human evidence behind them are duller and better documented, and we go through them in myostatin and ageing.
Frequently asked questions
Is Epithalon the same thing as Epitalon?
Yes. It is one molecule with two spellings. FDA and PubChem write Epitalon, and the peptide market generally writes Epithalon. PubChem CID 219042 covers it under the formula C14H22N4O9 with a molecular weight of 390.35. A seller who lists them as separate products is not a careful seller.
Can a doctor or a compounding pharmacy supply Epithalon?
No ordinary route exists. There is no FDA-approved Epithalon product, and the bulk substance nomination for epitalon was placed in category 2 under the interim policies and then withdrawn, leaving it on no current category list. A prescriber has nothing to write against and a pharmacy has nothing to compound from.
Does a 99.312% purity result mean the vial is safe?
It means 99.312% of the material assayed as the target molecule against a greater-than-98% specification. It says nothing about bacterial endotoxin, which is measured separately against its own limit, and nothing about whether the compound is safe to administer at all.
Why does the certificate say 9.64 mg when the label says 10 mg?
Because the fill was measured rather than assumed. The specification is 10 mg plus or minus 10 percent, so 9.64 mg is inside tolerance and under the printed weight. It also makes the real unit price on that batch $2.59 per milligram at the discounted price rather than $2.50.
Will Epithalon help my training at forty-five?
Nobody is claiming it will, including the people selling it. It is marketed on telomere and longevity claims, largely from one Russian research group, not replicated to Western standards, with no registered trials listing it as an intervention. Treat any page connecting it to strength or recovery as inventing.
Sources
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA
- Bulk Drug Substances Used in Compounding Under Section 503A, FDA
- Epitalon, PubChem CID 219042
- Certificate of analysis, Epithalon batch 15-05260628, Kovera Labs
- Published research on epitalon, PubMed
- Registered studies of Epitalon, ClinicalTrials.gov
This article is for educational purposes only and is not medical advice. Epithalon holds no FDA approval for any indication, has no US prescription route, and material sold by research suppliers is labelled for laboratory use only and not for human consumption. Claims about telomeres, telomerase and lifespan associated with this compound come largely from a single research lineage and have not been replicated to Western regulatory standards. Speak with a qualified healthcare professional before making any decision involving peptides, injections or unapproved compounds.